RAC Global Scope (RAC-GS) Practice Test

These questions are part of the practice quiz. Start practicing

• What does a CE mark indicate?
• A manufacturer of a permanently implanted active device is seeking guidance on conformance. What advice should be given?
• Which statement best describes post-market reporting obligations?
• What must be included in a Clinical Investigation Plan (CIP)?
• What role does prior examination content play in exam preparation for the RAC-GS?
• Explain the significance of Good Clinical Practice (GCP).
• When a device's sterility is compromised, which action should regulators consider first?
• When does a product change for a Class III medical device require National Body (NB) approval?
• Why is it important to understand cultural differences in global regulatory affairs?
• Which aspect of product development is most influenced by regulatory guidelines?
• Which type of study is crucial for establishing the safety of a new medication?
• What is the first recommended course of action for a company wishing to market a new Class III medical device quickly?
• The Declaration of Conformity supporting the CE marking of a Class I device does NOT include which of the following?
• What does "post-market reporting" involve?
• What is the duration of the RAC-GS exam?
• What is the most appropriate action for a regulatory professional when an auditor requests to be left alone in the records room?
• When assessing the link between a device and an adverse event, which factor is least relevant?
• How frequently do companies typically need to recertify compliance with regulations?
• What is the role of a regulatory affairs professional?
• What is a CE mark used for in relation to medical devices?
• What does the acronym FDA stand for?
• During an inspection of promotional materials, if a factual error is found that could lead to incorrect usage of a device, does it need to be reported?
• After submission to the regulatory authority, a substantial error was found in the application. In order to resolve this issue, what should be done FIRST?
• What action should a regulatory professional take after identifying a need for increased labeling accuracy?
• Which role does the FDA primarily fulfill in terms of regulatory oversight?
• What is the passing score range for the RAC-GS exam?
• Which document is crucial for ensuring compliance with regulatory requirements?
• What document outlines risk management in the context of product lifecycle?
• Which type of device does the MDD 93/42/EEC primarily regulate?
• What is a key factor in risk management during product development?
• What is the primary purpose of market entry strategies?
• In regulatory affairs, what does "CFR" stand for?
• After a serious incident with a device in the US, what should the Canadian regulatory professional recommend?
• Which components are required for document management to comply with ISO standards?
• What is the most crucial subject for the RA professional to discuss in a training session on new device indications for consumer disposable products?
• What is the role of a Regulatory Affairs Specialist in preclinical development?
• What does the term 'pharmaceutical compliance' generally refer to?
• What is the role of the European Medicines Agency (EMA)?
• What is the purpose of a Pre-Market Approval (PMA)?
• What is the role of a regulatory professional during product recalls?
• Which source should the regulatory professional consult to determine when a product's patent and exclusivity will expire?
• What does GxP stand for?
• When preparing an internal audit plan, what does a regulatory professional need to consider?
• What does the term "regulatory pathway" refer to?
• After a new regulation is introduced, what is the first step for a regulatory affairs professional if 60 percent of the company's products do not comply?
• A company is developing a device-drug combination product. Which should be evaluated FIRST to determine app guidance docs?
• What are post-approval changes, and why must they be monitored?
• In regulatory practice, what is the significance of the product lifecycle?
• According to GHTF guidelines, which class of medical device would NOT require a premarket on-site inspection?
• What is the duration of the RAC Global Scope certification validity?
• What is the main purpose of risk management in product development?
• What is the first action a company should take if it finds that one site in a clinical study has not properly consented all subjects?
• What is one benefit of understanding industry standards for RAC-GS exam candidates?
• When planning to make a custom-made device for a customer, what CE marking strategy is required?
• What is the purpose of an Investigational New Drug (IND) application?
• What does RAC stand for in the context of the Global Scope?
• Which regulation governs medical devices in Europe?
• A regulatory affairs professional is asked to review and update regulatory affairs SOPs. Which aspect is MOST important to consider?
• What is necessary for a manufacturer to CE mark a device containing electrical parts that may cause EMC interference under MDD 93/42/EEC?
• Where would you find regulatory requirements for advertising and promotion?
• When a device has serious complaints, what is the regulatory professional's first contact?
• What type of authorization must be obtained for a product before it can be marketed?
• A company receives multiple complaints regarding text included on a recently launched label. What action should the regulatory affairs professional take FIRST?
• Which application is required before conducting clinical trials in Europe?
• A manufacturer is developing a bioresorbable plug classified under which category if it is "wholly or mainly absorbed"?
• Why is continuous monitoring of post-approval changes critical in the pharmaceutical industry?
• Which term describes the regulatory approval process specifically for biologics?
• For ongoing safety evaluation of a medical device, which document is typically used?
• What is the primary purpose of the RAC Global Scope (RAC-GS) exam?
• One month prior to the anticipated approval date for your product, the marketing application that you submitted has become the subject of an advisory committee meeting. The advisory committee members unanimously vote not to approve your product because of a safety concern. What would be your MOST appropriate response to the regulatory authority's request for additional information?
• How could consensus standards benefit a business in regulatory affairs?
• Which change can be submitted without an updated batch record for a modified release product?
• Which are the two primary categories of medical devices based on risk?
• In a regulatory context, what does 'labeling' refer to?
• In regulatory submissions, what does NDA stand for?
• What type of professionals is the RAC-GS certification aimed at?
• Which aspect is crucial for regulatory affairs regarding cultural differences?
• What is the purpose of the Drug Approval Process?
• What does GxP stand for and why is it important?
• What is one major global regulatory agency?
• Provide one example of a regulatory body outside the U.S.?
• What is an example of a medical device reportable event?
• If a company wants to expand labeling to include a new indication, what should the regulatory professional do first?
• Which regulation requires premarket notification for devices in the U.S.?
• If a manufacturer learns that an incident with their CE-marked device in a foreign hospital does not require a FSCA, whom should they inform?
• What parameters must be considered when selecting the primary package for a product?
• Which aspect is critical to maintaining quality in a clinical study across multiple sites?
• What is a consensus standard, and how does it relate to regulatory affairs?
• What is a key consideration when understanding pharmaceutical equivalence?
• What does a risk assessment typically involve in product management?
• What is the primary focus when conducting post-market surveillance of medical devices?
• What is the function of a Quality Management System (QMS)?
• Which of the following is NOT considered raw data in a preclinical study?
• If a company wants to destroy records of a second version of a non-implantable device, what is the correct action?
• What is the key purpose of the Device Master File (DMF)?
• A company is planning to launch its new List B (Annex II) IVD. What action should the regulatory professional recommend?
• What is the main goal of harmonization in global regulations?
• What are the chief components of a regulatory submission?
• What document outlines compliance with ethical standards in clinical trials?
• If an FDA reviewer has a lengthy list of questions regarding a submitted 510(k) application, what is the best course of action for a regulatory professional?
• What type of decision is typically reassessed in a first level appeal?
• Explain the term "non-compliance" in regulatory contexts.
• What is the significance of the Common Technical Document (CTD)?
• Which aspect of product lifecycle management is pivotal for compliance?
• What is a major area covered under global regulatory practices in the exam?
• What role do standard operating procedures (SOPs) play in regulatory compliance?
• What is the significance of regulatory submission fees?
• What is the main ethical consideration in clinical research?
• What type of analysis should be used to identify high-risk and critical parameters in a manufacturing process?
• What is a pre-market approval (PMA) application?
• What is a key component of regulatory compliance in product development?
• When multiple facilities are involved in the processing of a Class III device, what must the PMA holder ensure regarding quality systems?
• What document would typically outline the essential requirements for a medical device?
• What is an essential strategy for effective risk mitigation in regulatory practices?
• What should a company do regarding shelf-life labeling to ensure a medical device can be marketed quickly?
• Record keeping requirements for marketed products are primarily intended to provide assurance of which aspect?
• Which document outlines the regulatory requirements for clinical trials?
• What is BEST identified as a multidimensional combination of input variables and process parameters to ensure quality?
• What type of understanding is crucial for a successful RAC-GS exam candidate?
• Which of the following aspects should be evaluated when studying the aftermath of a device incident?
• What does risk assessment evaluate in regulatory affairs?
• A clinical trial of a medical device can begin how many days after notification is sent to the Competent Authority?
• At the last internal audit, a regulatory affairs professional identified a need for a corrective action for the manufacturing process. Which of the following stakeholders should be notified FIRST?
• What key competency areas are emphasized in the RAC-GS exam?
• What is the purpose of labeling regulations?
• Why is familiarity with global regulatory agencies important for professionals?
• What is the best course of action for a regulatory professional negotiating product labeling with the FDA?
• What should a regulatory affairs professional do first if they discover an off-label indication during a review of promotional materials?
• What is the main goal of the Global Harmonization Task Force (GHTF)?
• When developing a clinical evaluation document, which factor should be evaluated first?
• In biocompatibility assessment for medical devices, which standard is most relevant?
• Can the RAC-GS exam be taken online?
• What is an Investigational Device Exemption (IDE)?
• What is the most important regulatory requirement for a distributor of high-risk devices?
• What is the importance of performing biocompatibility testing for medical devices?
• What is the first recommended action when an audit report indicates that equipment installation/validation protocols do not meet requirements?
• What is the focus of the ISO regarding pharmaceuticals?
• What is the purpose of a first level appeal from the perspective of a device manufacturer?
• What is a "letter of intent" in regulatory submissions?
• How is "regulatory intelligence" defined?
• What key factor must be established before a regulatory professional can proceed with a clinical trial?
• Which documentation is required for all medical devices?
• What is the goal of continuous learning in regulatory affairs?
• What is the most appropriate recommendation for a regulatory professional when an error in a software subroutine has caused a serious injury?
• Name one international organization that sets standards for pharmaceuticals and medical devices.
• A global company has obtained a patent for a newly marketed product. What would be the BEST advice to protect the patent in other countries?
• What is the term for a situation where a company requests the return of a device that has not yet been shipped?
• Which of the following is MOST important when submitting a 510(k) application?
• What key document outlines the procedures and responsibilities in regulatory compliance?
• What is the primary difference between a Class I and Class III medical device?
• When a surgical mesh product faces a complaint trend, which documentation does NOT need to be completed by the regulatory professional for market retrieval of product?
• How can professionals prepare for the RAC-GS exam?
• What purpose do the International Conference on Harmonisation (ICH) guidelines serve?
• What is regulatory intelligence?
• What does CMC stand for in regulatory submissions, and why is it significant?
• What is the primary focus of the RAC-GS exam?
• Which key area includes regulations administered by the FDA?
• When filing for PMA of a Class III device, what information is required?
• What is a common outcome of effective post-marketing surveillance?
• Which type of testing is essential for demonstrating the long-term safety of a permanent implant?
• What is the goal of the Orphan Drug Act?
• What is the main purpose of labeling regulations in the pharmaceutical industry?
• Whom should a US based manufacturer inform of an incident involving a Class I medical device sold in Germany?
• What is the best strategy if a Notified Body disagrees with your device classification?
• What requirement must be met for informed consent in clinical studies?
• In the context of clinical trials, what does GCP stand for?
• Define “Risk-Based Approach” in regulatory affairs.
• Ensuring a medical device meets defined user needs and intended use is accomplished through which type of validation?
• Which area should professionals focus on while studying for the RAC-GS exam?
• What is typically included in a letter of intent?
• How do you define "pharmaceutical equivalence"?
• What is a significant factor when preparing for global product registration?
• What does RAC-GS stand for?
• What regulatory document is essential for the approval of a New Drug Application (NDA)?
• What does the term "adverse events" refer to?
• A company is developing a new medical device using innovative technology. Which of the following is MOST critical in working with regulatory authorities?
• Under which regulation would you classify a prescription drug?
• Why does the sole internal auditor in a small company not meet the requirements for performing internal quality system audits?
• What type of data is necessary for pharmaceutical approvals in the EU?
• What does the term "post-market surveillance" mean?
• If Company Y believes Company X is promoting its product as superior, what should Company Y's FIRST action be?
• According to ISO 14971, what is the FIRST step when developing a risk management plan for a device?
• What are the components of the global regulatory environment?
• What is the primary role of regulatory affairs professionals during product development?
• What is the main focus of evaluating complaints received about a medical device?
• Which organization administers the RAC-GS certification?
• What is the role of the Office of Regulatory Affairs (ORA) in the FDA?
• What is the significance of post-marketing surveillance?
• When marketing CE-marked devices as a system or procedure pack, what is the most appropriate initial action for the regulatory professional?
• What information must be included in an informed consent document?
• What impact does RAC certification have on professionals in regulatory affairs?
• What is a benefit of understanding the global regulatory environment for professionals?
• What is the focus of post-marketing studies?
• What is the function of a regulatory submission in product marketing?
• What is a submission timeline, and why is it significant?
• Who is the BEST person to conduct an internal audit if the internal audit procedure was written by an external consultant?
• Which of the following BEST demonstrates conformance with the Essential Requirements for a Class IIa device?
• What is one benefit of obtaining RAC certification?
• What is a "compassionate use" authorization?
• What is the recommended regulatory pathway for a medical device company developing a product with drug, biologic, and device components?
• To maintain a valid CE Mark for devices under Annex II, what should the manufacturer do?
• Which of the following best describes a regulatory agency's role in product development?
• What is the purpose of a regulatory compliance audit?
• Which group is required to comply with Good Manufacturing Practices (GMP)?
• In a situation where a manufacturer receives a classification challenge for its device, who ultimately has the authority to decide the correct classification?
• How does the regulatory framework for biopharmaceuticals differ from traditional pharmaceuticals?
• What type of document serves as a framework for managing compliance in the regulatory environment?
• What is the significance of clinical study design in regulatory submissions?
• Why might a regulatory agency request additional data after an initial submission?
• Which class of devices is not subject to regulatory quality system requirements?
• When can a clinical investigation begin for a Class I device after obtaining Ethics Committee approval?
• A US manufacturer CE marks its Class IIa medical device and labels it in multiple languages. If a distributor is contacted from Sweden requesting the product, what should they do?
• Which products are included in GHTF's guidance on labeling?
• What is the potential consequence of non-compliance in a regulatory environment?
• To whom is MDD 93/42/EEC directed?
• Who has the PRIMARY responsibility for recall of products with quality defects?
• During a product recall, what is a PRIMARY role of the Health Protection Branch?
• Which standard provides guidance on biocompatibility for materials used in medical devices?
• What global initiative focuses on the standardization of drug quality across countries?